1. Home
  2. WFCF vs CGTX Comparison

WFCF vs CGTX Comparison

Compare WFCF & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WFCF

Where Food Comes From Inc.

N/A

Current Price

$13.15

Market Cap

59.1M

Sector

Technology

ML Signal

N/A

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$1.71

Market Cap

158.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFCF
CGTX
Founded
1996
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.1M
158.8M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
WFCF
CGTX
Price
$13.15
$1.71
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.88
AVG Volume (30 Days)
3.7K
938.3K
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
45.82
N/A
EPS
0.53
N/A
Revenue
$25,512,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.26
$0.22
52 Week High
$13.78
$3.83

Technical Indicators

Market Signals
Indicator
WFCF
CGTX
Relative Strength Index (RSI) 60.00 51.98
Support Level $12.50 $1.69
Resistance Level $13.15 $1.77
Average True Range (ATR) 0.42 0.13
MACD 0.13 0.02
Stochastic Oscillator 100.00 74.44

Price Performance

Historical Comparison
WFCF
CGTX

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: